AIZN vs EXAS · $9.38B cap vs rev $2.76B
Assurant, Inc. 5.25% Subordinat (AIZN) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Assurant, Inc. 5.25% Subordinat (AIZN) common stock listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
AIZN does not have a complete income-statement cache yet.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
AIZN currently screens at market cap $9.38B. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the AIZN and EXAS stock pages for the full models.
Not investment advice.